CoChat

Targeting senescent cells for a healthier longevity: the roadmap for an era of global aging

Open access
Sun, Yu, Li, Qingfeng, Kirkland, James L · 2022 · Life Medicine

The DOI matches its Crossref record; 148 of the 149 references it cites were found in a registry or an index.

Abstract

Aging is a natural but relentless process of physiological decline, leading to physical frailty, reduced ability to respond to physical stresses (resilience) and, ultimately, organismal death. Cellular senescence, a self-defensive mechanism activated in response to intrinsic stimuli and/or exogenous stress, is one of the central hallmarks of aging. Senescent cells cease to proliferate, while remaining metabolically active and secreting numerous extracellular factors, a feature known as the senescence-associated secretory phenotype. Senescence is physiologically important for embryonic development, tissue repair, and wound healing, and prevents carcinogenesis. However, chronic accumulation of persisting senescent cells contributes to a host of pathologies including age-related morbidities. By paracrine and endocrine mechanisms, senescent cells can induce inflammation locally and systemically, thereby causing tissue dysfunction, and organ degeneration. Agents including those targeting damaging components of the senescence-associated secretory phenotype or inducing apoptosis of senescent cells exhibit remarkable benefits in both preclinical models and early clinical trials for geriatric conditions. Here we summarize features of senescent cells and outline strategies holding the potential to be developed as clinical interventions. In the long run, there is an increasing demand for safe, effective, and clinically translatable senotherapeutics to address healthcare needs in current settings of global aging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/lifemedi/lnac030

Cites

148 of 148 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Major timelines depicting historic milestones in cellular senescence research. The first theory defining inherent limitations of tissue self-renewal, cell proliferation and organismal developmental potential was proposed in 1891 by August Weissman, interpreting the distinction between the heritable germline and the perishable soma. In 1961, Hayflick et al. Moorhead reported the finite proliferation potential of human primary fibroblasts, which can be observed after serial passaging in culture and was termed “cellular senescence.” Years afterwards, numerous scientists not only confirmed this finding, but made continued and significant efforts to reveal mechanisms underlying senescence and to identify biological properties of senescent cells. As one of the critical breakthroughs in aging biology, several groups demonstrated that clearance of senescent cells via targeted agents in animal models and, more recently, in aged humans who typically develop chronic pathologies, can delay age-related dysfunction, and alleviate age-related diseases. The key breakthroughs are individually presented in the order of the name of major scientist, a brief description of the central finding or concept, as well as the year of the work published. “D + Q,” a combination of dasatinib and quercetin.
Figure 1. Major timelines depicting historic milestones in cellular senescence research. The first theory defining inherent limitations of tissue self-renewal, cell proliferation and organismal developmental potential was proposed in 1891 by August Weissman, interpreting the distinction between the heritable germline and the perishable soma. In 1961, Hayflick et al. Moorhead reported the finite proliferation potential of human primary fibroblasts, which can be observed after serial passaging in culture and was termed “cellular senescence.” Years afterwards, numerous scientists not only confirmed this finding, but made continued and significant efforts to reveal mechanisms underlying senescence and to identify biological properties of senescent cells. As one of the critical breakthroughs in aging biology, several groups demonstrated that clearance of senescent cells via targeted agents in animal models and, more recently, in aged humans who typically develop chronic pathologies, can delay age-related dysfunction, and alleviate age-related diseases. The key breakthroughs are individually presented in the order of the name of major scientist, a brief description of the central finding or concept, as well as the year of the work published. “D + Q,” a combination of dasatinib and quercetin.CC BY · PubMed Central
Figure 2. The impact of senescent cells on human aging and age-related pathologies and emerging interventions. During the lifespan senescent cells can accumulate, which secret a plethora of extracellular pro-inflammatory factors and/or other factors, collectively referred to as the SASP. Notably, some SASP components can not only reinforce cellular senescence per se, but induce passive senescence of adjacent and distant cells, together resulting in tissue remodeling and causing age-related organ dysfunction, such as nephropathy (presented as graphic symbols of the kidney, affected vs. healthy). Age-associated degeneration in several key organs contributes to organismal aging, affecting healthspan, and lifespan. As part of these recent advances, small molecule compounds that specifically target senescent cells (namely senotherapeutics, including senomorphics and senolytics) and minimize their detrimental effects in vivo are being intensively developed. Such agents with a potential to promote tissue rejuvenation, provide new therapeutic opportunities for intervening against multiple age-associated conditions. The clock at the center represents circadian rhythm or time relapse in the course of human aging.
Figure 2. The impact of senescent cells on human aging and age-related pathologies and emerging interventions. During the lifespan senescent cells can accumulate, which secret a plethora of extracellular pro-inflammatory factors and/or other factors, collectively referred to as the SASP. Notably, some SASP components can not only reinforce cellular senescence per se, but induce passive senescence of adjacent and distant cells, together resulting in tissue remodeling and causing age-related organ dysfunction, such as nephropathy (presented as graphic symbols of the kidney, affected vs. healthy). Age-associated degeneration in several key organs contributes to organismal aging, affecting healthspan, and lifespan. As part of these recent advances, small molecule compounds that specifically target senescent cells (namely senotherapeutics, including senomorphics and senolytics) and minimize their detrimental effects in vivo are being intensively developed. Such agents with a potential to promote tissue rejuvenation, provide new therapeutic opportunities for intervening against multiple age-associated conditions. The clock at the center represents circadian rhythm or time relapse in the course of human aging.CC BY · PubMed Central
Figure 3. Major characteristics and distinct markers of senescent cells. In response to endogenous stimuli and/or environmental stress, proliferating cells can be forced to into a stable and usually irreversible state of cell cycle arrest, termed cellular senescence. Of note, senescent cells are typically enlarged, flattened, exhibit an irregular cell shape, and develop a secretory phenotype, the SASP, which can be pro-inflammatory and pro-fibrotic. Their nuclear integrity is compromised due to the loss of Lamin B1 and nuclear exclusion of the HMGB1, with the appearance of extranuclear DNA species, particularly CCFs. Senescent cells display increased lysosomal content and enhanced SA-β-Gal activity, with an increased number of large but dysfunctional mitochondria producing high levels of ROS. There is often an elevated level of lipofuscin in the cytoplasm, up-regulated expression of p16INK4a/p21CIP1 and aberrant histone modifications in the nucleus. Biosynthesis and extracellular release of a number of pro-inflammatory factors as part of the SASP can be a prominent hallmark or feature of senescent cells. CCF, cytoplasmic chromatin fragments; HMGB1, high mobility group box 1. Dark red arrows, signal transduction initiated upon binding of extracellular ligands to their corresponding receptors at the plasma membrane. Blue arrows, generation and transportation of ROS in the senescent cell. Purple arrows, transition within and release of molecules from the nucleus. Yellow arrows, protein translation, posttranslational process, and extracellular release of SASP factors. White and black arrows beside molecules or organelles, up- or down-regulation of expression level or biological activity of indicated molecules in the nucleus (white) or the cytoplasm (black), individually.
Figure 3. Major characteristics and distinct markers of senescent cells. In response to endogenous stimuli and/or environmental stress, proliferating cells can be forced to into a stable and usually irreversible state of cell cycle arrest, termed cellular senescence. Of note, senescent cells are typically enlarged, flattened, exhibit an irregular cell shape, and develop a secretory phenotype, the SASP, which can be pro-inflammatory and pro-fibrotic. Their nuclear integrity is compromised due to the loss of Lamin B1 and nuclear exclusion of the HMGB1, with the appearance of extranuclear DNA species, particularly CCFs. Senescent cells display increased lysosomal content and enhanced SA-β-Gal activity, with an increased number of large but dysfunctional mitochondria producing high levels of ROS. There is often an elevated level of lipofuscin in the cytoplasm, up-regulated expression of p16INK4a/p21CIP1 and aberrant histone modifications in the nucleus. Biosynthesis and extracellular release of a number of pro-inflammatory factors as part of the SASP can be a prominent hallmark or feature of senescent cells. CCF, cytoplasmic chromatin fragments; HMGB1, high mobility group box 1. Dark red arrows, signal transduction initiated upon binding of extracellular ligands to their corresponding receptors at the plasma membrane. Blue arrows, generation and transportation of ROS in the senescent cell. Purple arrows, transition within and release of molecules from the nucleus. Yellow arrows, protein translation, posttranslational process, and extracellular release of SASP factors. White and black arrows beside molecules or organelles, up- or down-regulation of expression level or biological activity of indicated molecules in the nucleus (white) or the cytoplasm (black), individually.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 148 references

Research works printed but not linked: 1

  1. Xu, 2021, The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice, Nat Metab, 12, 1706, 10.1038/s42255-021-00491-8 · DOI · Paper page

Cited by

See all 112

Metadata

Authors
Sun, Y., Li, Q., & Kirkland, J. L.
Affiliations
  • Binzhou Medical University (CN)
  • Shanghai Jiao Tong University (CN)
  • Mayo Clinic (US)
Corresponding author
  • Sun, Yu
  • Li, Qingfeng
  • Kirkland, James L
Venue
Life Medicine
Published
2022-08-09
Volume
1
Issue
2
Pages
103-119
ISSN
2755-1733 (ISSN-L)
OpenAlex
W4299302962
Cited by
105
References
149
Citations by year
2026: 13 · 2025: 23 · 2024: 28 · 2023: 36 · 2022: 5
FWCI
3.17
Type
journal article
Language
en
Open access
Locations
  • Life Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Key Research and Development Program of China (2020YFC2002800, 2016YFC1302400)
  • National Natural Science Foundation of China (81472709, 31671425, 31871380, 82130045, XDB39010500)
  • Key Laboratory of Tissue Microenvironment and Tumor of Chinese Academy of Sciences (201706, 202008, SHSMU-ZDCX20210400, SHSLCZDZK00901)
  • National Institutes of Health (R37 AG13925, R33 AG61456, R01 AG072301, R01 AG61414, P01 AG62413, UH3 AG56933)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
cellular senescence, senescence-associated secretory phenotype, senotherapeutics, aging, global aging, inflammaging, age-related diseases, paracrine signaling, clinical translation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting senescent cells for a healthier longevity: the roadmap for an era of global aging. https://app.cochat.ai/papers/10.1093/lifemedi/lnac030
The paper
Sun, Y., Li, Q., & Kirkland, J. L. (2022). Targeting senescent cells for a healthier longevity: the roadmap for an era of global aging. Life Medicine. https://doi.org/10.1093/lifemedi/lnac030

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.